Dr. Jonathan Holtz
Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- Georgetown University School of Medicine (2008)
- Years since graduation
- 18
- In the NPI registry since
- 2009
- Medicare patients seen, 2024
- 599
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2008Medical school: Georgetown University School of Medicine
- 2009Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Advanced Heart Failure and Transplant Cardiology Physician primary
PA license MD454775
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Heart Failure & Transplant Cardiology per capita by county →
Where they work
Hospitals
- UPMC Altoona Altoona, PA
- Penn Highlands Dubois Dubois, PA
- UPMC Bedford Memorial Everett, PA
- Conemaugh Nason Medical Center Roaring Spring, PA
- Conemaugh Miners Medical Center Hastings, PA
Medical groups
- University of Pittsburgh Physicians (4,236 clinicians)
- UPMC Altoona Regional Health Services, Inc. (187 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 599
- Services billed
- 2,726
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Anticoagulant management of patient taking warfarin | 606 | 21 |
| Established patient office or other outpatient visit, 30-39 minutes | 530 | 357 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 299 | 289 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 159 | 79 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 155 | 76 |
| Insertion of needle into vein for collection of blood sample | 126 | 33 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 92 | 92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 92 | 83 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 89 | 89 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 87 | 47 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Spironolactone Other prescribers in Altoona, PA | 922 |
| Eliquis (apixaban) Other prescribers in Altoona, PA | 696 |
| Metoprolol Succinate Other prescribers in Altoona, PA | 677 |
| Furosemide Other prescribers in Altoona, PA | 671 |
| Atorvastatin Calcium Other prescribers in Altoona, PA | 577 |
| Jardiance (empagliflozin) Other prescribers in Altoona, PA | 575 |
| Carvedilol Other prescribers in Altoona, PA | 462 |
| Entresto (sacubitril/valsartan) Other prescribers in Altoona, PA | 423 |
| Rosuvastatin Calcium Other prescribers in Altoona, PA | 414 |
| Potassium Chloride Other prescribers in Altoona, PA | 301 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 60 payments worth $1,063 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $246 |
|---|---|
| Zoll Services LLC (a/k/a Zoll Lifecor Corp) | $211 |
| Boston Scientific Corporation | $199 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $122 |
| Actelion Pharmaceuticals US, Inc. | $93.55 |
| E.r. Squibb & Sons, L.l.c. | $52.52 |
| Scpharmaceuticals Inc. | $48.68 |
| United Therapeutics Corporation | $37.96 |
| Food and Beverage | $1,063 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.